Canonical: https://ownershiptrace.com/13f/companies/909

# Who owns BIOCRYST PHARMACEUTICALS INC (BCRX)? Elite investor 13F holders

5 tracked elite investors reported holding BIOCRYST PHARMACEUTICALS INC as of 2026-06-30, including Renaissance Technologies LLC, Bridgewater Associates, D.E. Shaw, Gotham Asset Management, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | BIOCRYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 25302900.00 USD | 2530290.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | BIOCRYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4910570.00 USD | 491057.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | BIOCRYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4085290.00 USD | 408529.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | BIOCRYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1564210.00 USD | 156421.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | BIOCRYST PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1951280.00 USD | 195128.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)